Transcatheter treatment of severe aortic stenosis in patients with complex coronary artery disease: case series and proposed therapeutic algorithm

Author:

Soriano Francesco1,Montalto Claudio1ORCID,Calderone Dario1,Nava Stefano1,Esposito Giuseppe1,Saia Francesco2,Oreglia Jacopo A1,Søndergaard Lars3

Affiliation:

1. Interventional Cardiology, De Gasperis Cardio Center, Niguarda Hospital , Piazza Ospedale Maggiore, 3 20162 Milano , Italy

2. Cardiology Unit, Cardio-Thoracic-Vascular Department, IRCCS University Hospital of Bologna , Policlinico Sant'Orsola - Malpighi, Via Giuseppe Massarenti 9, 40138 Bologna , Italy

3. The Heart Centre, Rigshopitalet, Copenhagen University Hospital , Blegdamsvej 9, 2100 København , Denmark

Abstract

Abstract Background Patients with severe aortic stenosis (AS) and complex coronary artery disease with a clinical indication to both transcatheter aortic valve implantation (TAVI) and percutaneous coronary intervention (PCI) pose a clinical dilemma since it is unclear which lesion should be treated first and careful planning is required. Case summary We report two cases of AS with complex PCI (ASCoP) features. In the first one, easy coronary cannulation with an Acurate Neo2 valve and commissural alignment was predicted; therefore, TAVI was performed first, and subsequently complex high-risk PCI of the left main was performed in the same procedure but without the burden of ongoing severe AS. In the second case, complex coronary cannulation after TAVI with an Evolut PRO valve was predicted; therefore, balloon aortic valvuloplasty and Impella placement were performed first to allow for complex, high-risk multivessel PCI and subsequent TAVI. In both cases, a single-stage approach was preferred to reduce the use of large-bore arterial access with possible consequent adverse events. Discussion In this case series, we illustrate a possible approach to the treatment of ASCoP patients. In such complex cases, a thorough preprocedural planning is mandatory, and clinical decision-making should be centred upon the predicted chance of cannulation of coronary arteries after TAVI.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. 2021 ESC/EACTS guidelines for the management of valvular heart disease;Vahanian;Eur Heart J,2021

2. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines;Otto;Circulation,2021

3. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients;Leon;N Engl J Med,2016

4. Transcatheter versus surgical aortic-valve replacement in high-risk patients;Smith;N Engl J Med,2011

5. Mechanical circulatory support and intravascular lithotripsy in high-risk patients undergoing percutaneous coronary intervention and transcatheter aortic valve replacement: a case series;Marchese;Eur Hear J Case Rep,2021

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3